These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9674705)

  • 1. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis.
    Watson RH; Neville PJ; Roy WJ; Hitchcock A; Campbell IG
    Oncogene; 1998 Jul; 17(2):207-12. PubMed ID: 9674705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours.
    Roy WJ; Watson RH; Hitchcock A; Campbell IG
    Oncogene; 1997 Oct; 15(17):2031-5. PubMed ID: 9366520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
    Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G
    Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus.
    Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G
    Oncogene; 1996 Oct; 13(8):1815-8. PubMed ID: 8895529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of benign ovarian tumors.
    Thomas NA; Neville PJ; Baxter SW; Campbell IG
    Int J Cancer; 2003 Jul; 105(4):499-505. PubMed ID: 12712441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of PPP2R1B gene alterations in primary ovarian cancers.
    Campbell IG; Manolitsas T
    Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity.
    Zborovskaya I; Gasparian A; Karseladze A; Elcheva I; Trofimova E; Driouch K; Trassard M; Tatosyan A; Lidereau R
    Int J Cancer; 1999 Sep; 82(6):822-6. PubMed ID: 10446448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
    Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
    Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in laryngeal cancer.
    Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
    Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An allelotype study of primary and corresponding recurrent glioblastoma multiforme].
    Hu J; Jiang CC; Ng HK; Pang JC; Tong CY; Chen SQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):56-8. PubMed ID: 12579503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.